TrialJournal of acquired immune deficiency syndromes (1999)2014

A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Jeffrey M Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.